Loss of E-cadherin leads to upregulation of NFkappaB activity in malignant melanoma

Oncogene
S KuphalA K Bosserhoff

Abstract

Malignant transformation of melanocytes frequently coincides with loss of E-cadherin expression. Here, we show that loss of E-cadherin leads to induction of nuclear factor kappa B (NFkappaB) activity in melanoma cell lines. Melanoma cells show constitutively active NFkappaB, whereas no activity is found in primary melanocytes. After re-expression of E-cadherin in melanoma cells, strong downregulation of NFkappaB activity was found. Consistently, NFkappaB activity was induced in primary human melanocytes after inhibition of E-cadherin activity by functionally blocking anti-E-cadherin antibodies. Interestingly, re-expression of E-cadherin-blocked p38 MAPK activity and the p38 MAPK inhibitors SB203580 and SB202190 almost completely prevented NFkappaB activation in melanoma cells. Furthermore, cytoplasmatic beta-catenin induced p38 and NFkappaB activation in malignant melanoma. To our knowledge, this is the first report suggesting a correlation between E-cadherin and NFkappaB activity in melanocytes and melanoma cells. In summary, we conclude that loss of E-cadherin and cytoplasmatic beta-catenin induces p38-mediated NFkappaB activation, potentially revealing an important mechanism of tumorigenesis in malignant melanomas.

References

Apr 1, 1991·The Journal of Cell Biology·U H FrixenW Birchmeier
Mar 23, 1995·Nature·L ShapiroW A Hendrickson
Nov 8, 1994·Proceedings of the National Academy of Sciences of the United States of America·P Cowin
Jan 5, 1996·The Journal of Biological Chemistry·A K BosserhoffR Buettner
Feb 4, 1997·Proceedings of the National Academy of Sciences of the United States of America·M TorresP Gruss
Nov 1, 1996·Japanese Journal of Cancer Research : Gann·G TamuraR Satodate
May 23, 1998·The Journal of Biological Chemistry·W EnglaroR Ballotti
Apr 21, 1999·The Journal of Pathology·R SilyeM Pignatelli
Nov 5, 1999·Molecular Cell Biology Research Communications : MCBRC·F NolletF van Roy
Feb 13, 2001·The Journal of Clinical Investigation·A S Baldwin
Feb 24, 2001·Cellular and Molecular Life Sciences : CMLS·A Novak, S Dedhar
Mar 29, 2002·Clinical & Experimental Metastasis·Carsten DenkertSteffen Hauptmann
Jul 12, 2002·The Prostate·Junghan SuhArnold B Rabson

❮ Previous
Next ❯

Citations

Jun 14, 2006·Cancer Metastasis Reviews·Dave S B HoonKlaus Pantel
Apr 27, 2007·Cancer Metastasis Reviews·Richard Sullivan, Charles H Graham
Dec 18, 2007·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Sima SalahshorJames R Woodgett
Jan 7, 2009·The Journal of Experimental Medicine·Ramin MassoumiAnja K Bosserhoff
Dec 19, 2007·Photochemistry and Photobiology·Pablo Lopez-BergamiZe'ev Ronai
Feb 9, 2010·Pigment Cell & Melanoma Research·J EberleUNKNOWN German Melanoma Research Network of the German Cancer Aid
May 24, 2011·Pigment Cell & Melanoma Research·Ossia M EichhoffKeith S Hoek
Sep 15, 2011·Pigment Cell & Melanoma Research·Pablo Lopez-Bergami
May 7, 2009·Molecular Cancer Therapeutics·Tongzu LiuDoris Mangiaracina Benbrook
Apr 27, 2007·American Journal of Nephrology·Melanie GerstungJochen W U Fries
Dec 6, 2008·Breast Cancer Research : BCR·Elizabeth Fabre-GuillevinCécile Charrière-Bertrand
Dec 10, 2013·European Journal of Cell Biology·Melanie KappelmannSilke Kuphal
May 11, 2010·Journal of Mammary Gland Biology and Neoplasia·Antonio Garcia de HerrerosPierre Savagner
Sep 4, 2014·BioMed Research International·Xin Liu, Kent-Man Chu
Jul 22, 2005·Melanoma Research·Silke KuphalAnja K Bosserhoff
Oct 2, 2015·Proceedings of the National Academy of Sciences of the United States of America·Nicolas LoyerRoland Le Borgne
Jun 17, 2015·Experimental and Molecular Pathology·Kamesh R AyasollaPravin C Singhal
Feb 7, 2012·Biochimica Et Biophysica Acta·Antonio García de Herreros, Josep Baulida
Feb 27, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Silke KuphalAnja-Katrin Bosserhoff
May 15, 2007·The Journal of Investigative Dermatology·Christian J SchmittWiebke K Peitsch
Jun 19, 2007·Journal of Dermatological Science·Preety SharmaAimee S Payne
Dec 31, 2005·Annals of the New York Academy of Sciences·Keiran S M Smalley, Meenhard Herlyn
Jun 9, 2007·International Journal of Cancer. Journal International Du Cancer·Narasimharao BhagavathulaJames Varani
Dec 12, 2012·European Journal of Immunology·Jan Van den Bossche, Jo A Van Ginderachter
Apr 19, 2011·Experimental Dermatology·Anja Katrin BosserhoffSilke Kuphal
Jul 24, 2010·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Marc P Stemmler, Ivan Bedzhov
Jun 27, 2012·International Journal of Cancer. Journal International Du Cancer·Birgit KreisederChristoph Wiesner
May 7, 2014·Molecular Carcinogenesis·Esmeralda PonceMary B Sevigny
Aug 29, 2014·Journal of Cellular and Molecular Medicine·Wenjun DuXiaobo Li
Nov 17, 2011·Archives of Biochemistry and Biophysics·Silke Kuphal, Anja Katrin Bosserhoff

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aphasia

Aphasia affects the ability to process language, including formulation and comprehension of language and speech, as well as the ability to read or write. Here is the latest research on aphasia.

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.